Respiratorius AB
A research company developing innovative drug candidates, primarily for oncology.
RESP | SPGR
Overview
Corporate Details
- ISIN(s):
- SE0004550192 (+2 more)
- LEI:
- 5493001YRVZ5XYFEE615
- Country:
- Sweden
- Address:
- Scheeletorget 1, 223 81 Lund
- Website:
- https://www.respiratorius.com/
Description
Respiratorius AB is a research company focused on the development of innovative drug candidates. The company's primary area of development is oncology, with a specific goal of launching new treatments for aggressive lymphoma. In addition to its cancer program, the company's pipeline has historically included projects for respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD) and severe asthma. Respiratorius leverages expertise in clinical development, pharmaceutical research, and commercialization to advance its portfolio of potential new medicines.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Respiratorius AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Respiratorius AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Respiratorius AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-12-06 | Johan Drott | Other | Buy | 1,120 | N/A |
Peer Companies
